(CBZ) CBIZ - Overview
Sector: Industrials | Industry: Specialty Business Services | Exchange: NYSE (USA) | Market Cap: 1.712m USD | Total Return: -54% in 12m
Avg Turnover: 19.9M
EPS Trend: 91.2%
Qual. Beats: 1
Rev. Trend: 95.4%
Qual. Beats: 0
Warnings
High Debt/EBITDA (5.1) with thin interest coverage (1.8)
Tailwinds
No distinct edge detected
CBIZ, Inc. is a professional services provider headquartered in Independence, Ohio, delivering financial, insurance, and advisory solutions to small and medium-sized businesses, governmental bodies, and non-profit organizations across the United States and Canada. The company operates through three primary segments: Financial Services, Benefits and Insurance Services, and National Practices, covering specialized areas such as tax compliance, human capital management, and IT managed services.
The firm utilizes a diversified business model designed to capture multiple revenue streams from a single client base, often referred to as a cross-selling strategy within the professional services sector. Operating within the Research & Consulting Services industry, CBIZ benefits from the recurring nature of compliance-based work, such as annual tax filings and ongoing payroll administration, which provides a degree of insulation against cyclical economic volatility.
Investors looking for deeper insights into the companys valuation metrics might find ValueRay a useful tool for further analysis. By focusing on the mid-market segment, CBIZ avoids direct competition with Big Four accounting firms while maintaining a scale that allows for the acquisition of smaller, regional boutique practices to drive inorganic growth.
- Expansion through strategic acquisitions of regional accounting and insurance firms
- Demand for tax compliance and government healthcare consulting drives revenue
- Small and medium-sized business activity influences employee benefits enrollment
- Interest rate fluctuations impact fiduciary investment income and payroll float
- Regulatory shifts in tax code and healthcare law increase advisory demand
| Net Income: 154.3m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA 3.29 > 1.0 |
| NWC/Revenue: 5.14% < 20% (prev 15.89%; Δ -10.75% < -1%) |
| CFO/TA 0.06 > 3% & CFO 255.2m > Net Income 154.3m |
| Net Debt (2.42b) to EBITDA (469.7m): 5.14 < 3 |
| Current Ratio: 1.22 > 1.5 & < 3 |
| Outstanding Shares: last quarter (61.5m) vs 12m ago -4.06% < -2% |
| Gross Margin: 12.76% > 18% (prev 0.14%; Δ 1.26k% > 0.5%) |
| Asset Turnover: 60.09% > 50% (prev 47.04%; Δ 13.04% > 0%) |
| Interest Coverage Ratio: 1.76 > 6 (EBITDA TTM 469.7m / Interest Expense TTM 212.0m) |
| A: 0.03 (Total Current Assets 798.2m - Total Current Liabilities 655.9m) / Total Assets 4.63b |
| B: 0.25 (Retained Earnings 1.17b / Total Assets 4.63b) |
| C: 0.08 (EBIT TTM 372.5m / Avg Total Assets 4.61b) |
| D: 0.43 (Book Value of Equity 1.17b / Total Liabilities 2.74b) |
| Altman-Z'' = 2.02 = BBB |
| DSRI: 0.82 (Receivables 769.4m/735.4m, Revenue 2.77b/2.16b) |
| GMI: 1.06 (GM 12.76% / 13.57%) |
| AQI: 1.07 (AQ_t 0.72 / AQ_t-1 0.68) |
| SGI: 1.28 (Revenue 2.77b / 2.16b) |
| TATA: -0.02 (NI 154.3m - CFO 255.2m) / TA 4.63b) |
| Beneish M = -2.90 (Cap -4..+1) = A |
As of May 30, 2026, the stock is trading at USD 33.20 with a total of 691,477 shares traded.
Over the past week, the price has changed by +3.56%,
over one month by +0.09%,
over three months by +15.92% and
over the past year by -54.01%.
CBIZ has received a consensus analysts rating of 4.67. Therefore, it is recommended to buy CBZ.
- StrongBuy: 2
- Buy: 1
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 41 | 23.5% |
P/E Trailing = 12.5176
P/E Forward = 16.5289
P/S = 0.6185
P/B = 0.8908
P/EG = 1.4569
Revenue TTM = 2.77b USD
EBIT TTM = 372.5m USD
EBITDA TTM = 469.7m USD
Long Term Debt = 1.46b USD (from longTermDebt, last quarter)
Short Term Debt = 133.8m USD (from shortTermDebt, last quarter)
Debt = 2.44b USD (from shortLongTermDebtTotal, last quarter) + Leases 454.0m
Net Debt = 2.42b USD (calculated: Debt 2.44b - CCE 28.7m)
Enterprise Value = 4.13b USD (1.71b + Debt 2.44b - CCE 28.7m)
Interest Coverage Ratio = 1.76 (Ebit TTM 372.5m / Interest Expense TTM 212.0m)
EV/FCF = 17.26x (Enterprise Value 4.13b / FCF TTM 239.1m)
FCF Yield = 5.79% (FCF TTM 239.1m / Enterprise Value 4.13b)
FCF Margin = 8.64% (FCF TTM 239.1m / Revenue TTM 2.77b)
Net Margin = 5.57% (Net Income TTM 154.3m / Revenue TTM 2.77b)
Gross Margin = 12.76% ((Revenue TTM 2.77b - Cost of Revenue TTM 2.42b) / Revenue TTM)
Gross Margin QoQ = 26.63% (prev -9.35%)
Tobins Q-Ratio = 0.89 (Enterprise Value 4.13b / Total Assets 4.63b)
Interest Expense / Debt = 8.67% (Interest Expense 212.0m / Debt 2.44b)
Taxrate = 28.64% (64.9m / 226.5m)
NOPAT = 265.8m (EBIT 372.5m * (1 - 28.64%))
Current Ratio = 1.22 (Total Current Assets 798.2m / Total Current Liabilities 655.9m)
Debt / Equity = 1.29 (Debt 2.44b / totalStockholderEquity, last quarter 1.89b)
Debt / EBITDA = 5.14 (Net Debt 2.42b / EBITDA 469.7m)
Debt / FCF = 10.10 (Net Debt 2.42b / FCF TTM 239.1m)
Total Stockholder Equity = 1.85b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.35% (Net Income 154.3m / Total Assets 4.63b)
RoE = 8.32% (Net Income TTM 154.3m / Total Stockholder Equity 1.85b)
RoCE = 11.23% (EBIT 372.5m / Capital Employed (Equity 1.85b + L.T.Debt 1.46b))
RoIC = 6.47% (NOPAT 265.8m / Invested Capital 4.11b)
WACC = 6.47% (E(1.71b)/V(4.16b) * Re(6.88%) + D(2.44b)/V(4.16b) * Rd(8.67%) * (1-Tc(0.29)))
Discount Rate = 6.88% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 55.56 | Cagr: 9.87%
[DCF] Terminal Value 77.97% ; FCFF base≈177.9m ; Y1≈204.0m ; Y5≈300.2m
[DCF] Fair Price = 39.18 (EV 4.52b - Net Debt 2.42b = Equity 2.10b / Shares 53.6m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 91.15 | EPS CAGR: 24.60% | SUE: 1.97 | # QB: 1
Revenue Correlation: 95.36 | Revenue CAGR: 29.14% | SUE: -0.25 | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.82 | Chg30d=-2.05% | Revisions=-14% | Analysts=5
EPS next Quarter (2026-09-30): EPS=1.22 | Chg30d=+2.06% | Revisions=+14% | Analysts=5
EPS current Year (2026-12-31): EPS=4.07 | Chg30d=+7.78% | Revisions=+43% | GrowthEPS=+12.7% | GrowthRev=+2.9%
EPS next Year (2027-12-31): EPS=4.49 | Chg30d=+3.36% | Revisions=+25% | GrowthEPS=+10.5% | GrowthRev=+4.3%
[Analyst] Revisions Ratio: +43%